Business ❯ Biotechnology

Startups

Funding Colossal Biosciences Investment Acquisitions Micronoma Innovation Theranos Mergers and Acquisitions Research Funding Neuralink

AI‑Designed Miniproteins Can Switch GPCRs On or Off, Study Reports

A Nature paper shows a pipeline that pairs computational design with a native‑cell high‑throughput screen to create preclinical GPCR drug candidates.

Aurora Therapeutics Launches to Scale Bespoke Gene Editing for PKU

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Colossal’s ‘Dire Wolves’ Mark First Birthday as De‑Extinction Dispute Continues

FDA Grants Accelerated Approval to Forzinity, First Therapy for Barth Syndrome

Tulsi-28X Reverses Liver Fibrosis in Preclinical Studies, Readies for Human Trials

India Moves to Operationalize BioE3 Framework in Push for $300 Billion Bioeconomy by 2030

Colossal Biosciences Creates Genetically Modified Wolves with Dire Wolf Traits

Neumora’s Depression Drug Fails to Meet Goals in Key Phase 3 Trial

Archon Biosciences Unveils AI-Driven Antibody Cages with $20M Funding

FDA Identifies Issues at Neuralink's Animal Lab